Analysts Anticipate Quaker Chemical Corp (KWR) Will Post Quarterly Sales of $208.76 Million

Wall Street brokerages expect Quaker Chemical Corp (NYSE:KWR) to announce sales of $208.76 million for the current quarter, Zacks reports. Two analysts have issued estimates for Quaker Chemical’s earnings, with the lowest sales estimate coming in at $206.31 million and the highest estimate coming in at $211.20 million. Quaker Chemical posted sales of $191.25 million during the same quarter last year, which suggests a positive year over year growth rate of 9.2%. The business is expected to report its next earnings report on Tuesday, February 27th.

On average, analysts expect that Quaker Chemical will report full-year sales of $208.76 million for the current financial year, with estimates ranging from $812.00 million to $820.20 million. For the next year, analysts expect that the company will post sales of $853.49 million per share, with estimates ranging from $842.78 million to $864.20 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Quaker Chemical.

Several research analysts have weighed in on KWR shares. Zacks Investment Research raised Quaker Chemical from a “sell” rating to a “hold” rating in a research report on Tuesday, October 10th. ValuEngine cut Quaker Chemical from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. FBR & Co set a $165.00 price objective on Quaker Chemical and gave the stock a “hold” rating in a research report on Friday, October 27th. Finally, B. Riley set a $165.00 price target on Quaker Chemical and gave the company a “hold” rating in a research report on Monday, November 20th. One analyst has rated the stock with a sell rating and five have issued a hold rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $163.50.

Quaker Chemical (NYSE KWR) opened at $145.87 on Wednesday. The company has a debt-to-equity ratio of 0.16, a current ratio of 2.83 and a quick ratio of 2.25. Quaker Chemical has a 1 year low of $126.18 and a 1 year high of $165.93. The firm has a market capitalization of $1,978.67, a price-to-earnings ratio of 41.09, a price-to-earnings-growth ratio of 2.40 and a beta of 1.31.

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 31st. Stockholders of record on Wednesday, January 17th were given a dividend of $0.355 per share. The ex-dividend date was Tuesday, January 16th. This represents a $1.42 dividend on an annualized basis and a dividend yield of 0.97%. Quaker Chemical’s dividend payout ratio is presently 40.00%.

In other news, VP Ronald S. Ettinger sold 367 shares of the company’s stock in a transaction on Monday, November 13th. The stock was sold at an average price of $157.16, for a total transaction of $57,677.72. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Mark Douglas sold 1,575 shares of the company’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $164.23, for a total value of $258,662.25. The disclosure for this sale can be found here. Insiders have sold a total of 5,442 shares of company stock worth $881,040 in the last ninety days. Insiders own 3.60% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the company. Flinton Capital Management LLC lifted its position in shares of Quaker Chemical by 29.7% during the 2nd quarter. Flinton Capital Management LLC now owns 768 shares of the specialty chemicals company’s stock valued at $111,000 after buying an additional 176 shares during the last quarter. Advisor Group Inc. lifted its position in shares of Quaker Chemical by 15.6% during the 2nd quarter. Advisor Group Inc. now owns 954 shares of the specialty chemicals company’s stock valued at $139,000 after buying an additional 129 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new stake in Quaker Chemical during the 2nd quarter worth about $246,000. Virginia Retirement Systems ET AL purchased a new stake in Quaker Chemical during the 3rd quarter worth about $252,000. Finally, Amalgamated Bank lifted its holdings in Quaker Chemical by 5.1% during the 2nd quarter. Amalgamated Bank now owns 1,810 shares of the specialty chemicals company’s stock worth $263,000 after purchasing an additional 88 shares in the last quarter. 84.32% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Analysts Anticipate Quaker Chemical Corp (KWR) Will Post Quarterly Sales of $208.76 Million” was first published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/07/analysts-anticipate-quaker-chemical-corp-kwr-will-post-quarterly-sales-of-208-76-million.html.

Quaker Chemical Company Profile

Quaker Chemical Corporation is a provider of process fluids, chemical specialties, and technical expertise to a range of industries, including steel, aluminum, mining, aerospace, tube and pipe, cans and others. The Company’s segments include North America, Europe, Middle East and Africa (EMEA), Asia/Pacific and South America.

Get a free copy of the Zacks research report on Quaker Chemical (KWR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Quaker Chemical (NYSE:KWR)

Receive News & Ratings for Quaker Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quaker Chemical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply